Nifuroxazide Pharmaceutical Preparations in the Russian Federation. Publication One: Nomenclature, Chemical and Pharmaceutical Characteristics of the Preparations’ Composition
- 21 October 2021
- journal article
- Published by Publishing House OKI in Antibiotics and Chemotherapy
- Vol. 66 (7-8), 90-98
- https://doi.org/10.37489/0235-2990-2021-66-7-8-90-98
Abstract
One of the most used antimicrobial nitrofurans in Russian medical practice is nifuroxazide, which is distinguished by high therapeutic efficacy, drug safety, as well as economic availability in the treatment of acute bacterial diarrhea without deterioration of the general condition, fever, and intoxication. In the Russian Federation (RF), nifuroxazide preparations in general circulation are supplied by 19 domestic and foreign pharmaceutical organizations. The aim of this study was to analyze the nomenclature, as well as chemical and pharmaceutical characteristics of excipients (EXs) in the composition of nifuroxazide preparations, which received state registration in the RF. A comparative study of the chemical and pharmaceutical characteristics of EXs of 42 nifuroxazide preparations in the form of capsules, tablets, and suspension for oral administration was carried out. The pharmaco-economic status is noted and the demand prospects for all forms of nifuroxazide preparations in the RF are outlined. Quantitative and qualitative differences in the composition of the EXs of a number of nifuroxazide preparations in the form of capsules and suspensions has been shown.Keywords
This publication has 5 references indexed in Scilit:
- Nifuroxazide in the treatment of acute intestinal infections in children: results of meta-analysisInfekcionnye bolezni, 2020
- Travelers’ DiarrheaPublished by Elsevier BV ,2019
- The effectiveness of using nifuroxazide in acute intestinal infections of bacterial etiology in childrenInfekcionnye bolezni, 2018
- Interchangeability Criteria for Levofloxacin-Based Medicinal Products in the Russian FederationPharmaceutical Chemistry Journal, 2017
- Open Clinical Trial on Using Nifuroxazide Compared to Probiotics in Treating Acute Diarrhoeas in AdultsMateria Socio-Medica, 2016